Labarrière, Nathalie, 19..-....
Nathalie Labarriere researcher
Labarrière, Nathalie
VIAF ID: 172235198 (Personal)
Permalink: http://viaf.org/viaf/172235198
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Anti-CTLA-4 antibody / CTLA-4 molecule immuno-modulator mechanisms and its consequences on the reinforcement of anti-melanoma immune responses |
![]() |
Caractérisation de l'infiltrat lymphocytaire cd4 et étude des réponses immunitaires dans le cancer colorectal |
![]() |
Characterisation of normal and tumour cell populations and definition of shared epitopes from Human Endogenous Retroviruses (HERVs). |
![]() |
Characterization and influence of CD4 T lymphocites specific of telomerase in cancers. |
![]() |
Characterization of tumor extracellular vesicles in the context of oncolytic virotherapy. |
![]() |
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage |
![]() |
Développement de nouvelles stratégies d'immunothérapie cellulaire anti-tumorale basées sur la construction de cellules présentatrices d'antigènes artificielles. |
![]() |
Etude des mécanismes de résistance aux inhibiteurs de points de contrôle immunitaire ciblant l'axe PD-1/PD-L1 à l'aide de modèles précliniques |
![]() |
Etude des mécanismes moléculaires conférant aux cellules dendritiques XCR1+ leurs capacités à activer les lymphocytes cytotoxiques au cours d'une réponse antivirale et antitumorale |
![]() |
Etude des réponses lymphocytaires T CD4 anti-tumorales : de l'identification de cibles à leur utilisation pour l'immunomonitorage |
![]() |
Evaluation of SIRPγ/CD47 blockade as a therapeutic strategy in transplantation as well as chronic auto-immune and inflammatory diseases. |
![]() |
Expression de récepteurs inhibiteurs sur les lymphocytes T infiltrant les tumeurs du rein : signification biologique et clinique |
![]() |
Génération et étude du mode d'action d'anticorps immunomodulateurs multispécifiques dérivés de nanobodies ciblant les récepteurs inhibiteurs CD96, TIGIT et PD-L1 |
![]() |
Hepatocellular carcinoma : Anti-CD137 antibody targeted immunotherapy and tumorigenic potential of recombinant AAV. |
![]() |
hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote MELOE-1 translation in stressed melanoma cells |
![]() |
Identification de nouvelles cibles potentielles impliquées dans l'immunomodulation tumorale |
![]() |
Identification of antigens potentially implied in the efficiency of melanoma adoptive immunotherapy. |
![]() |
Identification of CD4-T-cell infiltrate and analysis of immune responses in colorectal cancer. |
![]() |
Identification of MSS colorectal cancers tumor antigens for immunotherapy development. |
![]() |
The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles.. |
![]() |
Impact of the Microbiome-Thymus Axis in the Efficacy of Androgen Deprivation and Immune-Surveillance in Prostate Cancer. |
![]() |
Implication des antigènes de groupes sanguins et de l'activité [alpha](1-2) fucosyltransférase dans la résistance tumorale et la tumorigénicité de cellules de carcinome colique |
![]() |
In vivo syngeneic tumor models with acquired resistance to therapies targeting the PD-1/PD-L1 axis. |
![]() |
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes |
![]() |
Induction de la tolérance allogénique par transfert de gène dans le foie |
![]() |
Mécanismes épigénétiques et influence du micro-environnement tumoral |
![]() |
MELOE-1 melanoma antigen : tissue-specific expression and immunogenicity. |
![]() |
MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma |
![]() |
Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology |
![]() |
Oncolytic virus-mediated vectorisation of innovative transgenes for tumour microenvironment immunomodulation. |
![]() |
Optimization of adoptive T-cell transfer approaches in melanoma : editing of immune checkpoint genes and combination therapies. |
![]() |
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy |
![]() |
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients |
![]() |
Radiothérapie interne vectorisée alpha anti-PD-L1 dans le traitement du mélanome |
![]() |
Régulation de l'expression de PD-1 sur des lymphocytes T spécifiques de mélanome et suivi immunologique de patients traités par immunothérapie anti-PD-1 |
![]() |
Study of antitumor CD4 T cell responses : from identification of targets to their use for immunomonitoring. |
![]() |
Study of CD4 T cell responses using a model of artificial antigen presenting cells expressing HLA class II molecules : interest for adoptive immunotherapy. |
![]() |
T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection |
![]() |
Which molecular mechanism allows XCR1+ DCs to activate killer lymphocytes during antiviral and antitumoral responses. |
![]() |